FDA Breakthrough Therapy News

Latest Articles

• FDA Grants Breakthrough Therapy Designation to WashU Medicine’s Off-the-Shelf CAR-T Immunotherapy for Aggressive T-Cell Cancers

  Published: Mar 31, 2026

  Section: Research

  The U.S. Food and Drug Administration has fast-tracked the approval process for WU-CART-007, a novel immunotherapy developed at Washington University School of Medicine to combat r...